Ocera Therapeutics, Inc.
OCRX
OCRX was delisted on the 8th of December, 2017.
29 hedge funds and large institutions have $22.4M invested in Ocera Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
67% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 6
7% more funds holding
Funds holding: 27 → 29 (+2)
4% more capital invested
Capital invested by funds: $21.5M → $22.4M (+$914K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
QF
QVT Financial
New York
|
+$613K |
| 2 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$520K |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$171K |
| 4 |
Renaissance Technologies
New York
|
+$160K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$64.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$141K |
| 2 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$137K |
| 3 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$59K |
| 4 |
Millennium Management
New York
|
-$52.1K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$35.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $9K | +$10.1K | +2,942 | New |
|
|
BIM
27
BlackRock Investment Management
Wilmington,
Delaware
| $7K | +$902 | +264 | +12% |
|
|
28
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1K | -$35.1K | -10,261 | -96% |
|
29
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $5 | – | – | – |
|
|
NI
30
Numeric Investors
Boston,
Massachusetts
| – | -$59K | -18,600 | Closed |
|
31
Wells Fargo
San Francisco,
California
| – | -$4K | -1,325 | Closed |
|
OCRX Hedge Fund Activity: Q4 2015 in Review
29 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Ocera Therapeutics, Inc. (OCRX) for Q4 2015, worth a combined $22.4M — up 4.3% from $21.5M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new OCRX positions and 2 closed out — a net gain of 2 holders — while 10 added to existing stakes and 6 trimmed.
The largest buyer was QVT Financial, adding an estimated $613K. The largest seller was Sabby Management, cutting an estimated $141K.
- 29 institutional investors held Ocera Therapeutics, Inc. (OCRX) as of Q4 2015, up from 27 in Q3 2015.
- Funds reported $22.4M of Ocera Therapeutics, Inc. stock for Q4 2015, up 4.3% quarter-over-quarter.
- 4 funds opened new Ocera Therapeutics, Inc. positions in Q4 2015 and 2 closed out, a net change of +2 holders.
- The largest Ocera Therapeutics, Inc. buyer in Q4 2015 was QVT Financial, an estimated $613K added.
- The largest Ocera Therapeutics, Inc. seller in Q4 2015 was Sabby Management, an estimated $141K sold.
Based on aggregated 13F filings for Q4 2015.